$FONR
FONAR CORP

2024 Q2 Form 10-K Financial Statement

#000035501924000038 Filed on September 27, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 2023
Revenue $25.94M $102.9M $98.65M
YoY Change 0.63% 4.3% 1.08%
Cost Of Revenue $15.35M $57.74M $52.90M
YoY Change 13.35% 9.16% 4.59%
Gross Profit $10.60M $45.14M $45.70M
YoY Change -13.44% -1.23% -2.79%
Gross Profit Margin 40.84% 43.87% 46.33%
Selling, General & Admin $8.823M $26.87M $29.39M
YoY Change -5.34% -8.58% 25.0%
% of Gross Profit 83.27% 59.52% 64.31%
Research & Development $439.0K $1.736M $1.568M
YoY Change -0.24% 10.73% 4.92%
% of Gross Profit 4.14% 3.85% 3.43%
Depreciation & Amortization $2.078M $4.596M $4.540M
YoY Change 76.12% 1.24% 0.11%
% of Gross Profit 19.61% 10.18% 9.93%
Operating Expenses $9.262M $28.60M $30.96M
YoY Change -5.11% -7.6% 23.8%
Operating Profit $1.333M $4.516M $11.13M
YoY Change -46.24% -59.42% 109.64%
Interest Expense $553.4K $2.075M $50.13K
YoY Change 25.77% 4039.95% -85.53%
% of Operating Profit 41.5% 45.96% 0.45%
Other Income/Expense, Net $32.62K $78.76K -$202.7K
YoY Change -138.85% -123.54%
Pretax Income $1.919M $19.27M $15.76M
YoY Change -34.27% 22.26% -30.79%
Income Tax $285.0K $5.169M $3.632M
% Of Pretax Income 14.85% 26.83% 23.05%
Net Earnings $778.9K $10.57M $9.376M
YoY Change -32.27% 12.71% -24.64%
Net Earnings / Revenue 3.0% 10.27% 9.5%
Basic Earnings Per Share
Diluted Earnings Per Share $0.12 $1.44 $1.25
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.48M $56.48M $51.30M
YoY Change 10.09% 10.09% 5.22%
Cash & Equivalents $56.34M $56.34M $51.30M
Short-Term Investments $136.1K $136.1K $0.00
Other Short-Term Assets $1.286M $1.286M $1.600M
YoY Change -19.63% -19.63% 44.88%
Inventory $2.715M $2.715M $2.600M
Prepaid Expenses
Receivables $4.035M $79.85M $70.20M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $140.3M $140.3M $125.7M
YoY Change 11.67% 11.63% 5.91%
LONG-TERM ASSETS
Property, Plant & Equipment $18.71M $57.67M $55.90M
YoY Change -15.52% 3.16% -2.68%
Goodwill $4.269M
YoY Change 0.0%
Intangibles $2.870M
YoY Change -16.36%
Long-Term Investments
YoY Change
Other Assets $7.704M $7.704M $10.60M
YoY Change -27.32% -27.32% -20.71%
Total Long-Term Assets $73.92M $73.92M $74.90M
YoY Change -1.33% -1.31% -7.14%
TOTAL ASSETS
Total Short-Term Assets $140.3M $140.3M $125.7M
Total Long-Term Assets $73.92M $73.92M $74.90M
Total Assets $214.2M $214.2M $200.6M
YoY Change 6.81% 6.8% 0.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.856M $1.856M $1.600M
YoY Change 17.52% 15.99% 3.14%
Accrued Expenses $8.483M $8.483M $8.600M
YoY Change -1.36% -1.36% -4.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $47.00K $272.8K $300.0K
YoY Change -70.41% -9.07% 19.89%
Total Short-Term Liabilities $17.86M $17.86M $15.60M
YoY Change 14.29% 14.47% -6.86%
LONG-TERM LIABILITIES
Long-Term Debt $66.94K $461.7K $700.0K
YoY Change -41.79% -34.05% -29.55%
Other Long-Term Liabilities $38.77M $38.77M $33.00M
YoY Change 17.48% 17.48% -6.11%
Total Long-Term Liabilities $39.60M $39.23M $33.70M
YoY Change 16.03% 16.41% -6.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.86M $17.86M $15.60M
Total Long-Term Liabilities $39.60M $39.23M $33.70M
Total Liabilities $57.46M $48.28M $42.70M
YoY Change 15.48% 13.06% -12.95%
SHAREHOLDERS EQUITY
Retained Earnings -$13.62M
YoY Change -43.68%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.017M
YoY Change 97.09%
Treasury Stock Shares
Shareholders Equity $166.0M $166.0M $157.9M
YoY Change
Total Liabilities & Shareholders Equity $214.2M $214.2M $200.6M
YoY Change 6.81% 6.8% 0.63%

Cashflow Statement

Concept 2024 Q2 2024 2023
OPERATING ACTIVITIES
Net Income $778.9K $10.57M $9.376M
YoY Change -32.27% 12.71% -24.64%
Depreciation, Depletion And Amortization $2.078M $4.596M $4.540M
YoY Change 76.12% 1.24% 0.11%
Cash From Operating Activities $4.597M $14.09M $14.47M
YoY Change 6.42% -2.58% -5.45%
INVESTING ACTIVITIES
Capital Expenditures $423.8K $790.0K $4.218M
YoY Change -39.45% -81.27% -7.2%
Acquisitions
YoY Change
Other Investing Activities $74.11K -$27.89K $0.00
YoY Change -100.0%
Cash From Investing Activities -$349.7K -$850.7K -$4.338M
YoY Change -50.04% -80.39% -16.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.888M -$8.181M -$7.572M
YoY Change -4.64% 8.04% 29.23%
NET CHANGE
Cash From Operating Activities 4.597M $14.09M $14.47M
Cash From Investing Activities -349.7K -$850.7K -$4.338M
Cash From Financing Activities -1.888M -$8.181M -$7.572M
Net Change In Cash 2.359M $5.061M $2.557M
YoY Change 43.87% 97.97% -40.02%
FREE CASH FLOW
Cash From Operating Activities $4.597M $14.09M $14.47M
Capital Expenditures $423.8K $790.0K $4.218M
Free Cash Flow $4.173M $13.30M $10.25M
YoY Change 15.29% 29.8% -4.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0000355019
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
CY2024 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
CY2023 FONR Amounts Capitalized
AmountsCapitalized
119571 usd
CY2024 FONR Software Or Patents Written Off
SoftwareOrPatentsWrittenOff
-225419 usd
CY2023 FONR Software Or Patents Written Off
SoftwareOrPatentsWrittenOff
0 usd
CY2024 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-369007 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-391591 usd
CY2024Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2870324 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
3431865 usd
CY2024 FONR Capital Stock Disclosure Textblock
CapitalStockDisclosureTextblock
<p id="xdx_80C_ecustom--CapitalStockDisclosureTextblock_zD1szU3WK4H2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 - <span id="xdx_828_zJhikIMjg9na">CAPITAL STOCK</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Common Stock</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_903_eus-gaap--DividendsPayableNature_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLrVfGdLc9W4" title="Dividends payable, nature">Cash dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class B Common Stock</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_903_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zHXG2OEjuIi9" title="Conversuion of shares into one-for-one basis">Class B common stock is convertible into shares of common stock on a one-for-one basis.</span> <span id="xdx_908_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ztQ5eGUQqoi6" title="Common stock, voting rights">Class B common stock has 10 votes per share.</span> There were <span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zSjtFcfBpUNl" title="Common stock, shares outstanding"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z2t3VxrjBu" title="Common stock, shares outstanding">146</span></span> of such shares outstanding at June 30, 2024 and 2023.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class C Common Stock</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90A_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdw8lY2faNv8" title="Common stock, voting rights">The Class C common stock has 25 votes per share</span>, as compared to 10 votes per share for the Class B common stock and <span id="xdx_90C_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfDoUeFYeS9" title="Common stock, voting rights">one vote per share for the common stock.</span> <span id="xdx_902_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL9aBo6vSOX8">The Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.</span> Although having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. <span id="xdx_90C_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zAL9kWUwKp4i">Class C common stock is convertible into shares of common stock on a three-for-one basis.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class A Non-Voting Preferred Stock</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a stock dividend on the Company’s common stock consisting of <span id="xdx_907_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zbCGzX4Iq4Sk">one share of Class A non-voting preferred stock for every five shares of common stock.</span> <span id="xdx_904_eus-gaap--DividendsPayableNature_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zo09MgJXnlRe">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such stock dividend approximates 313,000 shares.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next $20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company’s patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company’s patents.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock Bonus Plans</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zxlYUqSSnPd1" title="Common stock, capital shares reserved for future issuance">2,000,000</span> shares of common stock. On August 10, 2010, the Company filed Form S-8 to register the <span id="xdx_90A_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zs0dmncvVWbe" title="Shares registered">2,000,000</span> shares. As of June 30, 2024, <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zewLkGWB5kL7" title="Number of shares available for future grant">450,177</span> shares of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2024 and 2023, <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230701__20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zUicNQ8RZAx5" title="Number of shares were issued"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220701__20230630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zTieJANGutxj" title="Number of shares were issued">0</span></span> shares were issued.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Treasury Stock</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_901_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20220925__20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zd63ALfSTw93" title="Payments for repurchase of equity">9</span> million to be repurchased under the plan which will be purchased on the publicly traded open market at prevailing prices.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes the cost method of accounting to value the treasury stock when repurchasing stock. Under this method, the shares are valued at the price paid and recorded to treasury stock. When the treasury stock is cancelled, the par value of the stock is reduced and the additional paid in capital is reduced for the remaining value based upon the original stock sale. For the year ended June 30, 2024, the Company purchased <span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_c20230701__20240630_zL2RInDExWQ9" title="Purchase of treasury shares">156,206</span> shares at a cost of $<span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20230701__20240630_zh5RR7drRSFd" title="Purchase of treasury stock">2,505,832</span> and cancelled <span id="xdx_90F_ecustom--CancellationOfTreasuryShares_c20230701__20240630_z8qjbsWJnIjl" title="Cancellation of treasury shares">122,588</span> shares valued at $<span id="xdx_902_ecustom--CancellationOfTreasuryStock_c20230701__20240630_zxkEZOBtjq96" title="Cancellation of treasury stock">2,005,020</span>. For the year ended June 30, 2023, the Company purchased <span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodShares_c20220701__20230630_zyt0He4RBsn9" title="Purchase of treasury shares">103,148</span> shares at a cost of $<span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20220701__20230630_ztYQ1MHrW7xl" title="Purchase of treasury stock">1,759,457</span> and cancelled <span id="xdx_900_ecustom--CancellationOfTreasuryShares_c20220701__20230630_zX8YjFScYHB9" title="Cancellation of treasury shares">103,328</span> shares valued at $<span id="xdx_903_ecustom--CancellationOfTreasuryStock_c20220701__20230630_z5yFAJ01Ftr9" title="Cancellation of treasury stock">1,919,027</span>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
CY2024 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
156206 shares
CY2024 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2505832 usd
CY2024 FONR Cancellation Of Treasury Shares
CancellationOfTreasuryShares
122588 shares
CY2024 FONR Cancellation Of Treasury Stock
CancellationOfTreasuryStock
2005020 usd
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
103148 shares
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1759457 usd
CY2023 FONR Cancellation Of Treasury Shares
CancellationOfTreasuryShares
103328 shares
CY2023 FONR Cancellation Of Treasury Stock
CancellationOfTreasuryStock
1919027 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
113940 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
158842 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
47002 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
43767 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
66938 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
115075 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
47002 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
50448 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
16490 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
113940 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7223255 usd
CY2024Q2 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Policyholders Surplus
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus
371560 usd
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1323000 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
4516000 usd
CY2024 us-gaap Other Operating Income
OtherOperatingIncome
618000 usd
CY2024Q2 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
2746000 usd
CY2023 FONR Gain On Sale Of Equipment Related Party
GainOnSaleOfEquipmentRelatedParty
usd
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-2464137
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
110 Marcus Drive
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Melville
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11747
CY2024 dei City Area Code
CityAreaCode
631
CY2024 dei Local Phone Number
LocalPhoneNumber
694-2929
CY2024 dei Security12b Title
Security12bTitle
Common Stock, $.0001 par value
CY2024 dei Trading Symbol
TradingSymbol
FONR
CY2024 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
121000000.0 usd
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Auditor Name
AuditorName
Marcum
CY2024 dei Auditor Firm
AuditorFirmId
688
CY2024 dei Auditor Location
AuditorLocation
New York, NY
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56341193 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51279707 usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
136102 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
32799 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
166049 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
198593 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4035336 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3861512 usd
CY2024Q2 FONR Medical Receivable
MedicalReceivable
23991533 usd
CY2023Q2 FONR Medical Receivable
MedicalReceivable
21259262 usd
CY2024Q2 FONR Management And Other Receivable Allowances For Doubtful Accounts
ManagementAndOtherReceivableAllowancesForDoubtfulAccounts
12369921 usd
CY2023Q2 FONR Management And Other Receivable Allowances For Doubtful Accounts
ManagementAndOtherReceivableAllowancesForDoubtfulAccounts
12608567 usd
CY2024Q2 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
41953657 usd
CY2023Q2 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
35888253 usd
CY2024Q2 FONR Related Party Receivable Allowances For Doubtful Accounts
RelatedPartyReceivableAllowancesForDoubtfulAccounts
6110399 usd
CY2023Q2 FONR Related Party Receivable Allowances For Doubtful Accounts
RelatedPartyReceivableAllowancesForDoubtfulAccounts
3989692 usd
CY2024Q2 FONR Managment And Other Fees Receivable Related Medical Practices Net Allowances
ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
9865061 usd
CY2023Q2 FONR Managment And Other Fees Receivable Related Medical Practices Net Allowances
ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
9161870 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
2715441 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
2569666 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1285962 usd
CY2024 FONR Percentage Of Excise Tax
PercentageOfExciseTax
0.01 pure
CY2024 FONR Corporate Alternative Minimum Tax Percentage
CorporateAlternativeMinimumTaxPercentage
0.15 pure
CY2024Q2 us-gaap Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital
DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital
171000 usd
CY2023Q2 us-gaap Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital
DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital
78000 usd
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
429873 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2024 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1943588 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1607768 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
140324285 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
125660837 usd
CY2024Q2 FONR Accounts Receivable Net Long Term
AccountsReceivableNetLongTerm
829473 usd
CY2023Q2 FONR Accounts Receivable Net Long Term
AccountsReceivableNetLongTerm
710085 usd
CY2024Q2 FONR Note Receivable Related Party
NoteReceivableRelatedParty
581183 usd
CY2023Q2 FONR Note Receivable Related Party
NoteReceivableRelatedParty
0 usd
CY2024Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
7223255 usd
CY2023Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10041960 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18708920 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22146373 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38427757 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33068755 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
530348 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
729229 usd
CY2024Q2 us-gaap Goodwill
Goodwill
4269277 usd
CY2023Q2 us-gaap Goodwill
Goodwill
4269277 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2870324 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3431865 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
481147 usd
CY2023Q2 us-gaap Other Assets
OtherAssets
523506 usd
CY2024Q2 us-gaap Assets
Assets
214245969 usd
CY2023Q2 us-gaap Assets
Assets
200581887 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
47002 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
43767 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1855879 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1579240 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7941039 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5443724 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3473674 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3905484 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
225786 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
217597 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3870229 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3832184 usd
CY2024Q2 FONR Customer Deposits
CustomerDeposits
443471 usd
CY2023Q2 FONR Customer Deposits
CustomerDeposits
602377 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17857080 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
15624373 usd
CY2024Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1174844 usd
CY2023Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
760242 usd
CY2024Q2 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
371560 usd
CY2023Q2 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
394758 usd
CY2024Q2 FONR Accounts Payable Related Party Noncurrent
AccountsPayableRelatedPartyNoncurrent
92663 usd
CY2023Q2 FONR Accounts Payable Related Party Noncurrent
AccountsPayableRelatedPartyNoncurrent
92663 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37467746 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32105405 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
394723 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
620481 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
66938 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
115075 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
652521 usd
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2373461 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
652521 usd
CY2024 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2585515 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2770980 usd
CY2024 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
209992 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
208570 usd
CY2024 FONR Deferred Income Tax Expenses Benefit
DeferredIncomeTaxExpensesBenefit
2795507 usd
CY2023 FONR Deferred Income Tax Expenses Benefit
DeferredIncomeTaxExpensesBenefit
2979550 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5168968 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3632071 usd
CY2024 FONR Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rates
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates
0.210 pure
CY2023 FONR Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rates
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates
0.210 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.071 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.051 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.053 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.046 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.022 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.028 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.023 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.002 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.005 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.020 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.015 pure
CY2024Q2 us-gaap Other Liabilities
OtherLiabilities
32026 usd
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
41750 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
39600500 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
34130374 usd
CY2024Q2 us-gaap Liabilities
Liabilities
57457580 usd
CY2023Q2 us-gaap Liabilities
Liabilities
49754747 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180607510 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
182612518 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13623585 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24190981 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
45081 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11463 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1016632 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
515820 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
165967997 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
157906433 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
-9179608 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
-7079293 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
156788389 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
150827140 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
214245969 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
200581887 usd
CY2024 FONR Patient Fee Revenue Net Of Contractual Allowances And Discounts
PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
33815796 usd
CY2023 FONR Patient Fee Revenue Net Of Contractual Allowances And Discounts
PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
29793993 usd
CY2024 FONR Product Sales Net
ProductSalesNet
737727 usd
CY2023 FONR Product Sales Net
ProductSalesNet
731607 usd
CY2024 FONR Service And Repair Fees Net
ServiceAndRepairFeesNet
7452212 usd
CY2023 FONR Service And Repair Fees Net
ServiceAndRepairFeesNet
7419104 usd
CY2024 FONR Service And Repair Fees Related Parties Net
ServiceAndRepairFeesRelatedPartiesNet
139167 usd
CY2023 FONR Service And Repair Fees Related Parties Net
ServiceAndRepairFeesRelatedPartiesNet
110000 usd
CY2024 FONR Management And Other Fees Net
ManagementAndOtherFeesNet
48789287 usd
CY2023 FONR Management And Other Fees Net
ManagementAndOtherFeesNet
48640497 usd
CY2024 FONR Management And Other Fees Related Medical Practices Net
ManagementAndOtherFeesRelatedMedicalPracticesNet
11949900 usd
CY2023 FONR Management And Other Fees Related Medical Practices Net
ManagementAndOtherFeesRelatedMedicalPracticesNet
11949900 usd
CY2024 us-gaap Revenues
Revenues
102884089 usd
CY2023 us-gaap Revenues
Revenues
98645101 usd
CY2024 FONR Costs Related To Product Sales
CostsRelatedToProductSales
1052159 usd
CY2023 FONR Costs Related To Product Sales
CostsRelatedToProductSales
852025 usd
CY2024 FONR Costs Related To Service And Repair Fees
CostsRelatedToServiceAndRepairFees
3577570 usd
CY2023 FONR Costs Related To Service And Repair Fees
CostsRelatedToServiceAndRepairFees
3033967 usd
CY2024 FONR Costs Related To Service And Repair Fees Related Parties
CostsRelatedToServiceAndRepairFeesRelatedParties
144413 usd
CY2023 FONR Costs Related To Service And Repair Fees Related Parties
CostsRelatedToServiceAndRepairFeesRelatedParties
44983 usd
CY2024 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
18199579 usd
CY2023 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
16183166 usd
CY2024 FONR Costs Related To Management And Other Fees
CostsRelatedToManagementAndOtherFees
28626595 usd
CY2023 FONR Costs Related To Management And Other Fees
CostsRelatedToManagementAndOtherFees
26975563 usd
CY2024 FONR Costs Related To Management And Other Fees Related Medical Practices
CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
6143728 usd
CY2023 FONR Costs Related To Management And Other Fees Related Medical Practices
CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
5807454 usd
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1735949 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1567749 usd
CY2024 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26868732 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29390932 usd
CY2024 us-gaap Costs And Expenses
CostsAndExpenses
86348725 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
83855839 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
16535364 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
14789262 usd
CY2024 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
76997 usd
CY2023 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
50131 usd
CY2024 FONR Investment Income Related Party
InvestmentIncomeRelatedParty
25959 usd
CY2023 FONR Investment Income Related Party
InvestmentIncomeRelatedParty
0 usd
CY2024 us-gaap Investment Income Net
InvestmentIncomeNet
2126439 usd
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
1222176 usd
CY2024 FONR Other Income Related Party
OtherIncomeRelatedParty
576857 usd
CY2023 FONR Other Income Related Party
OtherIncomeRelatedParty
0 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
78763 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-202720 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19266385 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15758587 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5168968 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3632071 usd
CY2024 us-gaap Profit Loss
ProfitLoss
14097417 usd
CY2023 us-gaap Profit Loss
ProfitLoss
12126516 usd
CY2024 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3530021 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2750740 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
10567396 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
9375776 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
146236281 usd
CY2023 us-gaap Profit Loss
ProfitLoss
12126516 usd
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1759457 usd
CY2023 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5776200 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
150827140 usd
CY2024 us-gaap Profit Loss
ProfitLoss
14097417 usd
CY2024 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2505832 usd
CY2024 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5630336 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
156788389 usd
CY2024 us-gaap Profit Loss
ProfitLoss
14097417 usd
CY2023 us-gaap Profit Loss
ProfitLoss
12126516 usd
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4596421 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4540135 usd
CY2024 FONR Provision For Bad Debts
ProvisionForBadDebts
1882061 usd
CY2023 FONR Provision For Bad Debts
ProvisionForBadDebts
5513476 usd
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2795507 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2979550 usd
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4311762 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4264818 usd
CY2024 FONR Gain On Sale Of Equipment Related Party
GainOnSaleOfEquipmentRelatedParty
581183 usd
CY2024 FONR Gainloss On Disposition Of Fixed Assets
GainlossOnDispositionOfFixedAssets
75411 usd
CY2023 FONR Gainloss On Disposition Of Fixed Assets
GainlossOnDispositionOfFixedAssets
-213244 usd
CY2024 FONR Abandoned Patents
AbandonedPatents
225419 usd
CY2023 FONR Abandoned Patents
AbandonedPatents
0 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11676139 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8055843 usd
CY2024 FONR Increase Decrease In Notes Receivable
IncreaseDecreaseInNotesReceivable
55200 usd
CY2023 FONR Increase Decrease In Notes Receivable
IncreaseDecreaseInNotesReceivable
-64532 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
145775 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
209845 usd
CY2024 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-266606 usd
CY2023 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
438911 usd
CY2024 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-42359 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2763 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
276639 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19685 usd
CY2024 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2949962 usd
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-2527100 usd
CY2024 FONR Increase Decrease In Customer Advance
IncreaseDecreaseInCustomerAdvance
-158906 usd
CY2023 FONR Increase Decrease In Customer Advance
IncreaseDecreaseInCustomerAdvance
241132 usd
CY2024 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4541352 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3862814 usd
CY2024 us-gaap Increase Decrease In Trading Liabilities
IncreaseDecreaseInTradingLiabilities
-217569 usd
CY2023 us-gaap Increase Decrease In Trading Liabilities
IncreaseDecreaseInTradingLiabilities
-210353 usd
CY2024 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-9724 usd
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-64791 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14093294 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14467130 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
789961 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4218084 usd
CY2024 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
103303 usd
CY2023 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
473 usd
CY2024 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
75411 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2024 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
32885 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
119571 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-850738 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4338128 usd
CY2024 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
44902 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
36615 usd
CY2024 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
2505832 usd
CY2023 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1759457 usd
CY2024 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5630336 usd
CY2023 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5776200 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8181070 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7572272 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5061486 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2556730 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51279707 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48722977 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56341193 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51279707 usd
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.230 pure
CY2024Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1323000 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zqEKKHEfG9S9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zDrffM0Rk6Ua">Use of Estimates</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances, income taxes and related tax asset valuation allowances, contingencies, and revenue recognition. In addition, healthcare industry reforms and reimbursement practices will continue to impact the Company’s operations and the determination of contractual and other allowance estimates. Actual results could differ from those estimates.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
2948000 usd
CY2023 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
2801000 usd
CY2024Q2 FONR Management Agreements With Company Total Medical Practices
ManagementAgreementsWithCompanyTotalMedicalPractices
22 pure
CY2024Q2 FONR Scanners With Management Agreements With Company Owned By Related Party
ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty
3 pure
CY2024Q2 FONR Scanners With Management With Company Located In New York State
ScannersWithManagementWithCompanyLocatedInNewYorkState
19 pure
CY2024 FONR Net Patient Fee Revenue
NetPatientFeeRevenue
33815796 usd
CY2023 FONR Net Patient Fee Revenue
NetPatientFeeRevenue
29793993 usd
CY2024 FONR Provision For Bad Debts
ProvisionForBadDebts
1882061 usd
CY2022Q3 FONR Management Fee Receivable For Unrelated Parties
ManagementFeeReceivableForUnrelatedParties
33419219 usd
CY2022Q3 FONR Management Fee Receivable For Related Parties
ManagementFeeReceivableForRelatedParties
8602561 usd
CY2022Q3 FONR Accounts Receivable Service Contracts Net
AccountsReceivableServiceContractsNet
4335956 usd
CY2024 us-gaap Advertising Expense
AdvertisingExpense
731000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
570000 usd
CY2024 us-gaap Income Tax Examination Penalties Expense
IncomeTaxExaminationPenaltiesExpense
20444 usd
CY2023 us-gaap Income Tax Examination Penalties Expense
IncomeTaxExaminationPenaltiesExpense
31122 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
3969819 usd
CY2024 FONR Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders
NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
127504 shares
CY2023 FONR Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders
NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
127504 shares
CY2024 FONR Net Income Loss Available To Common Stockholder Basic
NetIncomeLossAvailableToCommonStockholderBasic
10567396 usd
CY2024 FONR Weighted Average Shares Outstanding Basic
WeightedAverageSharesOutstandingBasic
6350862 shares
CY2024 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.66
CY2023 FONR Net Income Loss Available To Common Stockholder Basic
NetIncomeLossAvailableToCommonStockholderBasic
9375776 usd
CY2023 FONR Weighted Average Shares Outstanding Basic
WeightedAverageSharesOutstandingBasic
6539376 shares
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.43
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zjfBs4dogapf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_zTIqGj8fSFsd">Concentration of Credit Risk</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2024, the Company had cash on deposit of approximately $<span id="xdx_907_eus-gaap--Cash_iI_pp0p0_c20240630_zls9uqywcjkh" title="Cash deposit">53,883,000</span> in excess of federally insured limits of $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20240630_zBSk8mx3ekc3" title="Federally insured limits">250,000</span>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zcUvQhEqKW3f" title="Concentration risk, percentage"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zSnnpyzSZ80h" title="Concentration risk, percentage">12</span></span>% of the consolidated net revenues for the years ended June 30, 2024 and 2023. Net management fee receivables from the related party medical practices accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_z9UgZHdapRv" title="Concentration risk, percentage">12</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zrb3soJNEv93" title="Concentration risk, percentage">13</span>% of the consolidated accounts receivable as of June 30, 2024 and 2023, respectively.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 3 regarding the Company’s concentrations in the healthcare industry.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
CY2024Q2 us-gaap Cash
Cash
53883000 usd
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
3360809 usd
CY2024Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
758700 usd
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
707400 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
396092 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2768844 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1323018 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2981214 usd
CY2024Q2 FONR Accounts Receivable Net Long Term
AccountsReceivableNetLongTerm
829473 usd
CY2023Q2 FONR Accounts Receivable Net Long Term
AccountsReceivableNetLongTerm
710085 usd
CY2024Q2 us-gaap Contract Receivable Due Two To Three Years
ContractReceivableDueTwoToThreeYears
631415 usd
CY2024Q2 us-gaap Contract Receivable Due Three To Four Years
ContractReceivableDueThreeToFourYears
369429 usd
CY2024Q2 us-gaap Contract Receivable Due Four To Five Years
ContractReceivableDueFourToFiveYears
87000 usd
CY2024Q2 us-gaap Contract Receivable Due Five Years Or More
ContractReceivableDueFiveYearsOrMore
87000 usd
CY2024Q2 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
1174844 usd
CY2024 FONR Percentage Of Consolidated Net Revenue From Management Fees
PercentageOfConsolidatedNetRevenueFromManagementFees
0.12 pure
CY2023 FONR Percentage Of Consolidated Net Revenue From Management Fees
PercentageOfConsolidatedNetRevenueFromManagementFees
0.12 pure
CY2024 FONR Total Facilities Owned Or Managed At Beginning Of Year
TotalFacilitiesOwnedOrManagedAtBeginningOfYear
27 integer
CY2023 FONR Total Facilities Owned Or Managed At Beginning Of Year
TotalFacilitiesOwnedOrManagedAtBeginningOfYear
27 integer
CY2024 FONR Managed Facilities Added By Internal Development
ManagedFacilitiesAddedByInternalDevelopment
1 integer
CY2023 FONR Managed Facilities Added By Internal Development
ManagedFacilitiesAddedByInternalDevelopment
1 integer
CY2024 FONR Managed Facilities Closed During Year
ManagedFacilitiesClosedDuringYear
0 integer
CY2023 FONR Managed Facilities Closed During Year
ManagedFacilitiesClosedDuringYear
-1 integer
CY2024 FONR Total Facilities Owned Or Managed At End Of Year
TotalFacilitiesOwnedOrManagedAtEndOfYear
28 integer
CY2023 FONR Total Facilities Owned Or Managed At End Of Year
TotalFacilitiesOwnedOrManagedAtEndOfYear
27 integer
CY2024Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
2524201 usd
CY2023Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
2346300 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
191240 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
223366 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
2715441 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
2569666 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
62507377 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
61717416 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43798457 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39571043 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18708920 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22146373 usd
CY2024Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
747407 usd
CY2023Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
369675 usd
CY2024Q2 FONR Deferred Tax Assets In Right Use Assets And Liabilities
DeferredTaxAssetsInRightUseAssetsAndLiabilities
114116 usd
CY2023Q2 FONR Deferred Tax Assets In Right Use Assets And Liabilities
DeferredTaxAssetsInRightUseAssetsAndLiabilities
112938 usd
CY2024Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
106879 usd
CY2023Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
105310 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064 pure
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.036 pure
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
5685008 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
5887390 usd
CY2024 FONR Depreciation Of Leased Equipment
DepreciationOfLeasedEquipment
198881 usd
CY2023 FONR Depreciation Of Leased Equipment
DepreciationOfLeasedEquipment
198881 usd
CY2024 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
26534 usd
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
35833 usd
CY2024 FONR Finance Lease Cost
FinanceLeaseCost
225415 usd
CY2023 FONR Finance Lease Cost
FinanceLeaseCost
234714 usd
CY2024 FONR Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
6363561 usd
CY2023 FONR Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
5577578 usd
CY2024 FONR Financing Cash Flows From Financing Leases
FinancingCashFlowsFromFinancingLeases
244344 usd
CY2023 FONR Financing Cash Flows From Financing Leases
FinancingCashFlowsFromFinancingLeases
244344 usd
CY2024 FONR Rightofuse Equipment Assets Obtained In Exchange For Lease Obiligations Operating Leases
RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
3715138 usd
CY2023 FONR Rightofuse Equipment Assets Obtained In Exchange For Lease Obiligations Operating Leases
RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
2902584 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20314658 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20507192 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17444334 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17075327 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2870324 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3431865 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
351882 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
339179 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
326502 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
320232 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
313052 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1219477 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2870324 usd
CY2024 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P9Y10M24D
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
3431865 usd
CY2022Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
3703885 usd
CY2024 FONR Amounts Capitalized
AmountsCapitalized
32885 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7416031 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10406190 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
192776 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
364230 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7223255 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
10041960 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
267124 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
151007 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
104436 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
243751 usd
CY2024Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
371560 usd
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
394758 usd
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
6851695 usd
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
9647202 usd
CY2024Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4677690 usd
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4413044 usd
CY2024Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
197317 usd
CY2023Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
193041 usd
CY2024Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1461336 usd
CY2023Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
48353 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
11207 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
11207 usd
CY2024Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
119800 usd
CY2023Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
100000 usd
CY2024Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
121445 usd
CY2023Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
100971 usd
CY2024Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
3534 usd
CY2023Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
3534 usd
CY2024Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1348710 usd
CY2023Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
573574 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7941039 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5443724 usd
CY2024 FONR Lease And Rental Expenses
LeaseAndRentalExpenses
5685000 usd
CY2023 FONR Lease And Rental Expenses
LeaseAndRentalExpenses
5887000 usd
CY2016Q1 FONR Property Tax Abatement From Suffolk County Ida
PropertyTaxAbatementFromSuffolkCountyIda
0.50 pure
CY2016Q1 FONR Property Tax Abatement
PropertyTaxAbatement
440000 usd
CY2024 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
0 usd
CY2023 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
36523 usd
CY2024Q2 us-gaap Reinsurance Payable
ReinsurancePayable
110000 usd
CY2024Q2 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
121000 usd
CY2023Q2 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
101000 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
76997 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
50132 usd
CY2024 us-gaap Income Taxes Paid
IncomeTaxesPaid
507139 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
1439507 usd
CY2017Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
23884 usd
CY2024 us-gaap Revenues
Revenues
102884089 usd
CY2024 FONR Intersegment Net Revenues
IntersegmentNetRevenues
1073333 usd
CY2024 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
16535364 usd
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4596421 usd
CY2024Q2 us-gaap Assets Net
AssetsNet
214245969 usd
CY2024 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
822846 usd
CY2023 us-gaap Revenues
Revenues
98645101 usd
CY2023 FONR Intersegment Net Revenues
IntersegmentNetRevenues
985833 usd
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
14789262 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4540135 usd
CY2023Q2 us-gaap Assets Net
AssetsNet
201046419 usd
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4337655 usd
CY2024 FONR Export Sales Of Medical Equipment Percentage
ExportSalesOfMedicalEquipmentPercentage
0.002 pure
CY2023 FONR Export Sales Of Medical Equipment Percentage
ExportSalesOfMedicalEquipmentPercentage
0.141 pure
CY2024 FONR Foreign Product Sales
ForeignProductSales
0.002 pure
CY2023 FONR Foreign Product Sales
ForeignProductSales
0.141 pure
CY2024 FONR Foreign Revenues Of Service And Repair Of Medical Equipment Percentage
ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
0.074 pure
CY2023 FONR Foreign Revenues Of Service And Repair Of Medical Equipment Percentage
ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
0.064 pure
CY2024 FONR Foreign Service And Repair Fees
ForeignServiceAndRepairFees
0.074 pure
CY2023 FONR Foreign Service And Repair Fees
ForeignServiceAndRepairFees
0.064 pure

Files In Submission

Name View Source Status
fonr-20240630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0000355019-24-000038-index-headers.html Edgar Link pending
0000355019-24-000038-index.html Edgar Link pending
0000355019-24-000038.txt Edgar Link pending
0000355019-24-000038-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fonar-performance_graph.jpg Edgar Link pending
fonar_10-k.htm Edgar Link pending
fonar_exhibit-21.htm Edgar Link pending
fonar_exhibit-23.htm Edgar Link pending
fonar_exhibit-31.htm Edgar Link pending
fonar_exhibit-32.htm Edgar Link pending
fonar_exhibit-97.htm Edgar Link pending
fonar_logo.jpg Edgar Link pending
fonr-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
fonr-20240630_def.xml Edgar Link unprocessable
fonr-20240630_lab.xml Edgar Link unprocessable
fonr-20240630_pre.xml Edgar Link unprocessable
fonar_10-k_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending